These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 8263805

  • 1. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM, Murphy DL.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [Abstract] [Full Text] [Related]

  • 2. Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.
    Andrews AM, Ladenheim B, Epstein CJ, Cadet JL, Murphy DL.
    Mol Pharmacol; 1996 Dec; 50(6):1511-9. PubMed ID: 8967972
    [Abstract] [Full Text] [Related]

  • 3. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA, Miller DB, Chisnell AC, Murphy DL, O'Callaghan JP, Andrews AM.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.
    Andrews AM, Murphy DL.
    Eur J Pharmacol; 1993 Dec 07; 250(2):215-21. PubMed ID: 8112382
    [Abstract] [Full Text] [Related]

  • 5. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL, Unger EL, Sheridan DL, Chisnell AC, Andrews AM.
    Mol Pharmacol; 2004 Sep 07; 66(3):718-27. PubMed ID: 15322265
    [Abstract] [Full Text] [Related]

  • 6. The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF.
    Luellen BA, Szapacs ME, Materese CK, Andrews AM.
    Neuropharmacology; 2006 Mar 07; 50(3):297-308. PubMed ID: 16288930
    [Abstract] [Full Text] [Related]

  • 7. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
    Szapacs ME, Numis AL, Andrews AM.
    Neurobiol Dis; 2004 Aug 07; 16(3):572-80. PubMed ID: 15262269
    [Abstract] [Full Text] [Related]

  • 8. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT, Irwin I, Delanney LE, Langston JW.
    J Pharmacol Exp Ther; 1995 May 07; 273(2):716-20. PubMed ID: 7752075
    [Abstract] [Full Text] [Related]

  • 9. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
    Unger EL, Mazzola-Pomietto P, Murphy DL, Andrews AM.
    J Pharmacol Exp Ther; 2002 Nov 07; 303(2):527-33. PubMed ID: 12388632
    [Abstract] [Full Text] [Related]

  • 10. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
    Andrews AM, Murphy DL.
    J Neurochem; 1993 Mar 07; 60(3):1167-70. PubMed ID: 8094744
    [Abstract] [Full Text] [Related]

  • 11. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
    Blier P, De Montigny C, Azzaro AJ.
    J Pharmacol Exp Ther; 1986 Jun 07; 237(3):987-94. PubMed ID: 2423685
    [Abstract] [Full Text] [Related]

  • 12. Interactions among deprenyl, clorgyline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on catecholamines in mice.
    Lee EH, Yang YL, Chia LG, Kuo JS.
    Neurosci Lett; 1994 Jan 03; 165(1-2):149-52. PubMed ID: 7912414
    [Abstract] [Full Text] [Related]

  • 13. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW, Hemrick-Luecke SK, Snoddy HD.
    J Pharmacol Exp Ther; 1994 Apr 03; 269(1):132-6. PubMed ID: 7513356
    [Abstract] [Full Text] [Related]

  • 14. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
    Ofori S, Heikkila RE, Nicklas WJ.
    J Pharmacol Exp Ther; 1989 Oct 03; 251(1):258-66. PubMed ID: 2571719
    [Abstract] [Full Text] [Related]

  • 15. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE, Nichols DE.
    J Pharmacol Exp Ther; 1995 May 03; 273(2):667-73. PubMed ID: 7538579
    [Abstract] [Full Text] [Related]

  • 16. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S, Zheng H, Fridkin M, Youdim MB.
    J Neurochem; 2005 Oct 03; 95(1):79-88. PubMed ID: 16181414
    [Abstract] [Full Text] [Related]

  • 17. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.
    Neuropharmacology; 2008 Nov 03; 55(6):1006-14. PubMed ID: 18761360
    [Abstract] [Full Text] [Related]

  • 18. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD, Mendels J, Frazer A.
    J Pharmacol Exp Ther; 1980 Feb 03; 212(2):259-63. PubMed ID: 7351637
    [Abstract] [Full Text] [Related]

  • 19. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F, Alessandrì MG, Torracca MT, Bassi L, Corsini GU.
    J Pharmacol Exp Ther; 1997 Oct 03; 283(1):100-7. PubMed ID: 9336313
    [Abstract] [Full Text] [Related]

  • 20. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
    Carli M, Afkhami-Dastjerdian S, Reader TA.
    J Psychiatry Neurosci; 1996 Mar 03; 21(2):114-22. PubMed ID: 8820177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.